CRISM Therapeutics Corporation (AIM:CRTX)
London
· Delayed Price · Currency is GBP · Price in GBX 13.00
+0.50 (4.00%)
Mar 9, 2026, 3:36 PM GMT
CRISM Therapeutics Market Cap
CRISM Therapeutics has a market cap or net worth of 6.47 million as of March 9, 2026. Its market cap has increased by 163.86% in one year.
Market Cap
6.47M
Enterprise Value
6.12M
Revenue
25.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
13.00
Market Cap Chart
Since March 15, 2006, CRISM Therapeutics's market cap has decreased from 28.23M to 6.47M, a decrease of -77.09%. That is a compound annual growth rate of -7.11%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cizzle Biotechnology Holdings | 6.14M |
| OptiBiotix Health | 5.94M |
| Nuformix | 5.80M |
| IXICO | 7.23M |
| Futura Medical | 7.39M |
| Theracryf | 4.41M |
| Genflow Biosciences | 9.91M |
| Oxford BioDynamics | 10.73M |